The first reaction of AMS metabolism, which converts 2-AMS to 2-aminomuconate (2-AM) is catalyzed by the enzyme encoded by the ALDH8A1 (aldehyde dehydrogenase 8 family member 1) gene
It helps to keep bones, teeth and muscles healthy
[Link] Acetyl-L-carnitine (ALCAR) is present in high concentrations in the brain, and it can be formed in the body or obtained through foods and can cross the blood-brain barrier
The overall response rate (ORR) for CM patients to ipilimumab, nivolumab, pembrolizumab and atezolizumab is 12%, 40%, 33% and 30% respectively (167169), while the combined treatment of ipilimumab with nivolumab significantly improves the ORR to 61% with median progression-free survival (PFS) of 11.5 months (170, 171)
Hospital grade and personalized to your goals